UNDERWRITING AGREEMENT between CANCER PREVENTION PHARMACEUTICALS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters CANCER PREVENTION PHARMACEUTICALS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 19th, 2016 • Cancer Prevention Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 19th, 2016 Company Industry JurisdictionThe undersigned, Cancer Prevention Pharmaceuticals, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries described in the Registration Statement (as hereinafter defined) as being subsidiaries of Cancer Prevention Pharmaceuticals, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Aegis Capital Corp. (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows: